GreatBay Bio to Showcase AI-Driven Bioprocessing Innovation at J.P. Morgan Week 2026
GBB
AI Biomedical R&D Company
The 44th J.P. Morgan Healthcare Conference, the largest and most information-rich international healthcare investment and business development conference in the global medical industry, will be held in San Francisco, USA, from January 12-15, 2026 (local time).This is the core platform that sets the tone for the industry's investment trends throughout the year and spawns major cooperation deals.At that time, the two major series of conferences, RESI (RESI JPM 2026) and BIO (BIO Partnering™ @JPM Week 2026), will open simultaneously.
GBB Chairman Guolong Liang and CEO Dr. Liang Chen to Jointly Attend RESI and BIO ConferencesOne-on-one dialogue with global industry leaders to jointly outline new pathways for biotechnology innovation and industrial development.Moreover, Mr. Liang Guolong will deliver a keynote speech at the RESI conference in the Golden Gate Room C3 of the San Francisco Marriott Marquis on Tuesday, January 13th, from 2:00 PM to 3:00 PM local time.Sharing how GBB, as a pioneer in the field of bioprocess intelligence, drives the transformation of the industry from "empirical science" to "precision industry" through multiple AI-driven intelligent drug development technology platforms, enhancing the core competitiveness of clients' drug license-out transactions and helping innovative drugs reach the market more quickly.
RESI JPM 2026 positions itself as a platform "connecting the entire investment cycle," leveraging its unique cross-border and cross-field attributes to precisely link startups in the four major fields of drugs, devices, diagnostics, and digital health with ten categories of global investors. It covers full-stage financing needs from seed rounds, angel rounds to Series A and Series B rounds, serving as an important engine for promoting the transformation of early life science innovations.
BIO Partnering™ @JPM Week 2026, as a highly influential industry benchmark event during JP Morgan Week, leverages the resource advantages of BIO, the world's largest biotechnology trade association. With its core feature of efficient and precise one-on-one matchmaking, the event will bring together over 500 companies and more than 700 industry participants worldwide, including multinational pharmaceutical companies, Biotech firms, investment institutions, and other key stakeholders, establishing a hub for collaboration and transactions in the global biotechnology field. This year’s event places greater emphasis on cutting-edge topics such as the application of AI and quantum computing in healthcare, as well as opportunities in the Asian market.
Email: BD@greatbay-bio.com
Phone: 18926497707 (Same for WeChat)
